{
    "nctId": "NCT04679454",
    "briefTitle": "Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer",
    "officialTitle": "Phase I/II Clinical Trial on Single Fraction Ablative Preoperative Radiation Treatment for Early Stage Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 79,
    "primaryOutcomeMeasure": "Phase I: Identify the maximum tolerated dose (MTD)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically proven unifocal adenocarcinoma\n* T1-T2\n* Tumor size up to 2.5 cm\n* cN0\n* Age \u2265 18 years old\n* Good general condition (ECOG 0-2)\n* Planned BCS\n* Written informed consent\n\nExclusion Criteria:\n\n* Tumor close to skin or chest wall\n* Pure non-invasive tumor\n* Prior RT to the chest\n* Neoadjuvant chemotherapy\n* Collagenopathies\n* Coagulation or autoimmunitary disorders\n* Previous malignancies",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}